Literature DB >> 30433848

Validation of Mayo Clinic Staging System for Light Chain Amyloidosis With High-Sensitivity Troponin.

Shaji K Kumar1, Morie A Gertz1, Angela Dispenzieri1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30433848     DOI： 10.1200/JCO.18.01398

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

1.  Predicting survival in light chain amyloidosis.

Authors:  Giovanni Palladini; Paolo Milani; Giampaolo Merlini
Journal:  Haematologica       Date:  2019-07       Impact factor: 9.941

Review 2.  Comprehensive approach to cardiac amyloidosis care: considerations in starting an amyloidosis program.

Authors:  Brett W Sperry; Julie A Khoury; Shahzad Raza; Julie L Rosenthal
Journal:  Heart Fail Rev       Date:  2021-08-30       Impact factor: 4.654

3.  Multidisciplinary team management and long-term prognosis of an elderly patient with severe cardiac amyloidosis complicated with multiple myeloma.

Authors:  Zhi Shang; Meng-Lin Zhao; Xin-Yu Wang; Wei Gao
Journal:  J Geriatr Cardiol       Date:  2022-05-28       Impact factor: 3.189

Review 4.  Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statement.

Authors:  Daniel Lenihan; Joseph Carver; Charles Porter; Jennifer E Liu; Susan Dent; Paaladinesh Thavendiranathan; Joshua D Mitchell; Anju Nohria; Michael G Fradley; Iskra Pusic; Keith Stockerl-Goldstein; Anne Blaes; Alexander R Lyon; Sarju Ganatra; Teresa López-Fernández; Rupal O'Quinn; Giorgio Minotti; Sebastian Szmit; Daniela Cardinale; Jose Alvarez-Cardona; Giuseppe Curigliano; Tomas G Neilan; Joerg Herrmann
Journal:  CA Cancer J Clin       Date:  2020-09-10       Impact factor: 508.702

Review 5.  Amyloidosis in Heart Failure.

Authors:  Sandra Ihne; Caroline Morbach; Laura Obici; Giovanni Palladini; Stefan Störk
Journal:  Curr Heart Fail Rep       Date:  2019-12

Review 6.  Amyloid and the Heart.

Authors:  Aaron M Wolfson; Kevin S Shah; Jignesh K Patel
Journal:  Curr Cardiol Rep       Date:  2019-12-03       Impact factor: 2.931

7.  Prognostic restaging after treatment initiation in patients with AL amyloidosis.

Authors:  Nadine Abdallah; Angela Dispenzieri; Eli Muchtar; Francis K Buadi; Prashant Kapoor; Martha Q Lacy; Yi L Hwa; Amie Fonder; Miriam A Hobbs; Suzanne R Hayman; Nelson Leung; David Dingli; John A Lust; Ronald S Go; Yi Lin; Wilson I Gonsalves; Taxiarchis Kourelis; Rahma Warsame; Robert A Kyle; S Vincent Rajkumar; Morie A Gertz; Shaji K Kumar
Journal:  Blood Adv       Date:  2021-02-23

Review 8.  The effect of intervention versus watchful waiting on disease progression and overall survival in smoldering multiple myeloma: a systematic review of randomized controlled trials.

Authors:  Ademola S Ojo; Somtochukwu G Ojukwu; Joseph Asemota; Oluwasegun Akinyemi; Mojisola O Araoye; Mohammed Saleh; Ahmed Ali; Ravi Sarma
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-20       Impact factor: 4.553

Review 9.  ATTR Amyloidosis: Current and Emerging Management Strategies: JACC: CardioOncology State-of-the-Art Review.

Authors:  Jan M Griffin; Julie L Rosenthal; Justin L Grodin; Mathew S Maurer; Martha Grogan; Richard K Cheng
Journal:  JACC CardioOncol       Date:  2021-10-19

Review 10.  Multimodal Imaging and Biomarkers in Cardiac Amyloidosis.

Authors:  Mi-Hyang Jung; Suyon Chang; Eun Ji Han; Jong-Chan Youn
Journal:  Diagnostics (Basel)       Date:  2022-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.